ACE2 and COVID-19: To confirm the presence of antibodies against ACE2 in sera from patients with COVID-19, a panel of 30 commercial serum samples collected from patients with COVID-19 and 60 serum samples from normal individuals were screened for the presence of antibodies against S1-RBD and ACE2 by ELISA.